Synbiotic Supplementation in Cyclists
The goal of this clinical trial is to assess the efficacy of a synbiotic blend on exercise performance and other exercise parameters in trained adult cyclists. It is hypothesized that those taking the synbiotic blend will have improved endurance exercise performance.

The primary objective is to assess the impact of a synbiotic on 20km distance trial performance in 36 cyclists. Secondary objectives include assessing the impact of the synbiotic on exercise metabolism, body composition, gastrointestinal and immune health.
- EligibilityCriteria: Inclusion Criteria:  Male or female between the ages of 18-45 Currently cycling for at least 3 hours per week for the past 3 months Free of any contraindications to exercise and any medical condition that could interfere with or influence metabolic or cardiovascular responses to exercise Have a resting heart rate <100 bpm and resting systolic and diastolic blood pressures <160 mmHg and <90 mmHg, respectively.  Exclusion Criteria:  Use of antibiotics or probiotic products within 4 weeks prior to study enrollment (note: participants will be eligible after a 2-week washout period) Current laxative use Are a smoker or use tobacco products Consume >21 units of alcohol per week Have donated blood in the previous 3 months Have a BMI ≥30kg/m2 Are pregnant or lactating or planning to become pregnant for the duration of the study Are dieting for weight loss or are following a low carbohydrate diet Have participated in another clinical trial within the 30 days preceding study enrollment Are taking medications known to affect cardiovascular or metabolic responses to exercise Have a medical condition that could interfere with study intervention and assessment Have current musculoskeletal injuries that limit exercise capacity Are non-English speaking - HealthyVolunteers: Accepts Healthy Volunteers - Gender: All - MinimumAge: 18 Years - MaximumAge: 45 Years - StdAgeList: Adult